Insulet Corporation's Wearable Pod Tech Faces Reality Check The recent quarterly performance of Insulet Corporation, a medical device company behind the Omnipod insulin management system, has raised concerns among investors.
A closer examination of the company's financials reveals that its innovative wearable technology is struggling to keep pace with escalating costs and regulatory hurdles.
Insulet's stock price took a hit last month after the company initiated another voluntary correction for certain lots of its Omnipod products due to a potentially life threatening defect in the cannula.